Institutional & Family Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Institutional & Family Asset Management’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-22	Closed	-$1K	–	872
2019 Q4	$1K	Hold	22	–	–	﹤0.01%	818
2019 Q3	$1K	Buy	22 +8	+57%	+$502	﹤0.01%	790
2019 Q2	$1K	Hold	14	–	–	﹤0.01%	807
2019 Q1	$1K	Hold	14	–	–	﹤0.01%	797
2018 Q4	$1K	Hold	14	–	–	﹤0.01%	775
2018 Q3	$2K	Hold	14	–	–	﹤0.01%	743
2018 Q2	$2K	Hold	14	–	–	﹤0.01%	728
2018 Q1	$1K	Buy	+14	New	+$1.39K	﹤0.01%	795

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

Institutional & Family Asset Management's LGND Position: Q1 2020 in Review

Institutional & Family Asset Management sold out of Ligand Pharmaceuticals (LGND) in Q1 2020, closing a stake of 22 shares — an estimated $1K sold.

Institutional & Family Asset Management first reported a position in LGND in Q1 2018 and held it in 8 quarters. The position peaked at $2K in Q3 2018. 262 funds tracked by Wall St. Rank hold LGND as of Q1 2020.

Institutional & Family Asset Management reported no remaining Ligand Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Institutional & Family Asset Management sold 22 Ligand Pharmaceuticals shares in Q1 2020, an estimated $1K.
Institutional & Family Asset Management first reported a position in Ligand Pharmaceuticals in Q1 2018 and held it in 8 quarters.
Institutional & Family Asset Management's Ligand Pharmaceuticals position peaked at $2K in Q3 2018.
262 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2020.

Based on Institutional & Family Asset Management's 13F filing for Q1 2020, filed 14 May 2020.